MIMostafa Izanlu

Mostafa Izanlu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mostafa Izanlu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Male Secretory Breast Carcinoma: Two Rare Case Reports and Literature Review

    by Fatemeh Homaei Shandiz, Asieh Sadat Fattahi, Mahsa Akbari Oryani, Mostafa Izanlu, Ehsan Hassanzadeh Haddad, Atefeh Sahebkari, Ahmad Saadat, Fariba Zabihi

    Background: Secretory breast carcinoma (SBC) is an uncommon type of breast cancer, accounting for less than 0.15% of all cases. Its occurrence in males is extremely uncommon and may result in diagnostic delay due to nonspecific clinical, radiologic, and histopathologic features. Methods: In this study, two cases of SBC with distinct clinical presentations are reported, including a 15‐year‐old adolescent and a 26‐year‐old man. Clinical findings, imaging characteristics, histopathologic features, immunohistochemical (IHC) profiles, treatment strategies, and outcomes were reviewed and analyzed in the context of the current literature. Results: Both patients presented with slowly growing breast masses and a triple‐negative profile that were diagnosed based on histopathology and IHC findings. In the adolescent case, sentinel lymph node biopsy revealed limited nodal metastasis, and the patient was treated with mastectomy followed by adjuvant chemotherapy and planned radiotherapy, with no evidence of recurrence at 6 months. Initially, the adult patient was misdiagnosed, which delayed the accurate diagnosis. Moreover, a rapid local progression occurred after initial excision due to the misdiagnosis. However, the patient showed a good clinical response after neoadjuvant chemotherapy, modified radical mastectomy(MRM), and radiotherapy. These cases highlighted the biological and clinical heterogeneity of SBC despite its generally favorable prognosis. Conclusion: SBC in males remains a diagnostic challenge due to its rarity and overlapping features with other benign and malignant breast lesions. The diagnosis of SBC requires high clinical suspicion, along with detailed histopathologic, immunophenotypic, and molecular evaluation. Individualized and multidisciplinary management and long‐term follow‐up are essential to optimize outcomes in this rare entity.

  • Decellularized human amniotic membrane engraftment in combination with adipose‐derived stem cells transplantation, synergistically improved diabetic wound healing

    by Sima Davoodi, Roohollah Ebrahimpour‐Malekshah, Ömer Ayna, Mitra Akbari, Amir Raoofi, Hossein Mokhtari, Mostafa Izanlu, Faezeh Modanloo, Davood Nasiry

    Background: One of the most important and common complications of diabetes is a disorder and defect in diabetic wound healing.Aims: The aim of present study was to investigate the synergistic effects of decellularized human amniotic membrane (dHAM) engraftment and adipose‐derived stem cells (ADSs) transplantation in the healing of delayed and ischemic diabetic wound.Methods: Sixty diabetic male rats were randomly divided into four groups (n = 15), including untreated (Control) group, engraftment by dHAM (dHAM) group, transplanted by ADSs (ADS) group, and engraftment by dHAM plus transplanted by ADSs (dHAM + ADS) group. Sampling was performed on Days 7, 14, and 21 after surgery. Evaluation tests included stereology, immunohistochemistry, molecular, and biomechanical.Results: Our results showed that the wound closure rate, volumes of newly formed epidermis and dermis, density of fibroblasts and blood vessels, collagen deposition, density of proliferation cells, expression levels of TGF‐β and VEGF genes, and biomechanical characteristics were significantly higher in all treated groups compared with control group; however, these changes were considerable in the combination group. This is while that the density of neutrophils and expression levels of TNF‐α and IL‐1β genes in the treated groups, especially in the combination group, were significantly reduced compared with control group.Conclusion: Generally, the simultaneous use of dHAM and ADS accelerates healing and improves the quality of repaired diabetic wounds.